TP53 and breast carcinoma: Since the co-authors first reported in 1991 that distinct immunoreaction with p53 in the nuclei of breast cancer cells is an independent prognostic indicator [15], more than 1000 articles about the correlation between p53 status and breast cancer prognosis have been published.